Stay updated on Prasinezumab in Early Parkinson's Disease Clinical Trial
Sign up to get notified when there's something new on the Prasinezumab in Early Parkinson's Disease Clinical Trial page.

Latest updates to the Prasinezumab in Early Parkinson's Disease Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedUpdated page notices and status details, including a new revision tag v3.2.0 with a 2025-09-30 date, replacing the old v3.1.0 (2025-07-08). Also added government funding lapse notice and operating status links.SummaryDifference10%

- Check29 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, indicating a minor version update. The 'Back to Top' element was removed; no core content, pricing, stock, or time-slot information appears to have changed.SummaryDifference0.5%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.5%

- Check58 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This suggests a shift towards a more generalized presentation of location data.SummaryDifference60%

- Check72 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.3%

Stay in the know with updates to Prasinezumab in Early Parkinson's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prasinezumab in Early Parkinson's Disease Clinical Trial page.